UTMB study shows potential treatment of Lassa fever with antiviral drug January 9, 2026 • 10:46 a.m. by Leslie Sanderson The research examines a promising antiviral approach with important implications for how Lassa fever may be treated during outbreaks. UTMB Health Elevates Weight Loss Management with Dr. Andrea Stark January 8, 2026 • 3:16 p.m. by Raegan Scharfetter An accomplished researcher, author, educator, lecturer, and mentor, Dr. Stark brings a comprehensive, evidence-based approach to care that reflects the latest advances in the field. UTMB bariatric surgery program earns designations for quality and excellence January 7, 2026 • 3:32 p.m. by Margaret Battistelli Gardner These achievements translate into expanded access to approved bariatric surgery services, greater flexibility within insurance networks, and the assurance that care meets nationally recognized quality benchmarks. UTMB, Circio partner to evaluate circVec for infectious diseases treatment January 7, 2026 • 10:41 a.m. The collaboration is an important component of UTMB's commitment to develop and strengthen its infectious disease, gene and cell therapy programs. UTMB IT Team Builds More than Systems, They Build Dreams December 22, 2025 • 1:46 p.m. by Melissa McDonald UTMB’s IT team came together during the holiday season to help build a home, reinforcing that health begins with safe, stable housing. Their hands-on effort not only supported a family’s dream but also showcased the team’s commitment to community and collaboration beyond technology. UTMB Health Designated as First Qualified Treatment Center in Texas for Zevaskyn December 22, 2025 • 10:02 a.m. by Stephen Hadley UTMB Health becomes a national leader in treating ultra-rare skin disease RDEB, earning designation as a Qualified Treatment Center for an FDA-approved gene therapy bringing first-of-its-kind care closer to home. Dr. Esosa Odigie-Okon chosen for leadership program for outstanding mid-career cardiologists December 17, 2025 • 3:20 p.m. by Margaret Battistelli Dr. Esosa Odigie-Okon, MD, MSc, FACC, clinical assistant professor of cardiology at UTMB, has been chosen by the American College of Cardiology to join its prestigious Sandra J. Lewis Mid-Career Women’s Leadership Institute. UTMB Health, In Collaboration with UTHealth Houston, Awarded $50 Million By The State Of Texas To Lead Ibogaine Clinical Trials December 12, 2025 • 4:37 p.m. by UTHealth Houston UTMB Health and UTHealth Houston are leading a groundbreaking $50 million statewide clinical trial to explore ibogaine as a potential treatment for addiction, PTSD, and traumatic brain injury — a first-of-its-kind effort that could put Texas at the forefront of behavioral health innovation. From Ideas to Impact: UTMB Leaders Named NAI Fellows December 12, 2025 • 9:20 a.m. by Melissa McDonald UTMB leaders join the ranks of the world’s top inventors. Learn how their work is transforming science and elevating UTMB’s role in advancing solutions that improve lives. UTMB Helps Lead Project Metis To Advance Global Innovation In Brain Health, The Brain Economy December 10, 2025 • 2:17 p.m. The University of Texas Medical Branch, Rice University and Memorial Hermann Health System are proud to announce the formal launch of Project Metis, a groundbreaking initiative led by Center for Houston’s Future to position the Houston/Galveston region as the global leader in brain health and the emerging brain economy. Search Categories Awards & Accolades Education Faculty/Staff News Health Care In The News Innovations News Releases Top News UTMB Research Contact Media Team UTMB Experts
UTMB study shows potential treatment of Lassa fever with antiviral drug January 9, 2026 • 10:46 a.m. by Leslie Sanderson The research examines a promising antiviral approach with important implications for how Lassa fever may be treated during outbreaks.
UTMB Health Elevates Weight Loss Management with Dr. Andrea Stark January 8, 2026 • 3:16 p.m. by Raegan Scharfetter An accomplished researcher, author, educator, lecturer, and mentor, Dr. Stark brings a comprehensive, evidence-based approach to care that reflects the latest advances in the field.
UTMB bariatric surgery program earns designations for quality and excellence January 7, 2026 • 3:32 p.m. by Margaret Battistelli Gardner These achievements translate into expanded access to approved bariatric surgery services, greater flexibility within insurance networks, and the assurance that care meets nationally recognized quality benchmarks.
UTMB, Circio partner to evaluate circVec for infectious diseases treatment January 7, 2026 • 10:41 a.m. The collaboration is an important component of UTMB's commitment to develop and strengthen its infectious disease, gene and cell therapy programs.
UTMB IT Team Builds More than Systems, They Build Dreams December 22, 2025 • 1:46 p.m. by Melissa McDonald UTMB’s IT team came together during the holiday season to help build a home, reinforcing that health begins with safe, stable housing. Their hands-on effort not only supported a family’s dream but also showcased the team’s commitment to community and collaboration beyond technology.
UTMB Health Designated as First Qualified Treatment Center in Texas for Zevaskyn December 22, 2025 • 10:02 a.m. by Stephen Hadley UTMB Health becomes a national leader in treating ultra-rare skin disease RDEB, earning designation as a Qualified Treatment Center for an FDA-approved gene therapy bringing first-of-its-kind care closer to home.
Dr. Esosa Odigie-Okon chosen for leadership program for outstanding mid-career cardiologists December 17, 2025 • 3:20 p.m. by Margaret Battistelli Dr. Esosa Odigie-Okon, MD, MSc, FACC, clinical assistant professor of cardiology at UTMB, has been chosen by the American College of Cardiology to join its prestigious Sandra J. Lewis Mid-Career Women’s Leadership Institute.
UTMB Health, In Collaboration with UTHealth Houston, Awarded $50 Million By The State Of Texas To Lead Ibogaine Clinical Trials December 12, 2025 • 4:37 p.m. by UTHealth Houston UTMB Health and UTHealth Houston are leading a groundbreaking $50 million statewide clinical trial to explore ibogaine as a potential treatment for addiction, PTSD, and traumatic brain injury — a first-of-its-kind effort that could put Texas at the forefront of behavioral health innovation.
From Ideas to Impact: UTMB Leaders Named NAI Fellows December 12, 2025 • 9:20 a.m. by Melissa McDonald UTMB leaders join the ranks of the world’s top inventors. Learn how their work is transforming science and elevating UTMB’s role in advancing solutions that improve lives.
UTMB Helps Lead Project Metis To Advance Global Innovation In Brain Health, The Brain Economy December 10, 2025 • 2:17 p.m. The University of Texas Medical Branch, Rice University and Memorial Hermann Health System are proud to announce the formal launch of Project Metis, a groundbreaking initiative led by Center for Houston’s Future to position the Houston/Galveston region as the global leader in brain health and the emerging brain economy.